The Technology Strategy Board’s Stratified Medicine Innovation Platform (SMIP) seeks to build on the UK’s strength within the global healthcare industries and put it at the centre of the next generation of medicine. Its seven partner organisations will together invest…
Development & Supply of Drug Product for Clinical Trials
Dstl (Defence Science and Technology Laboratory) has a requirement for a Contract Research Organisation (CRO) to undertake drug product development and supply to support a future Phase 1 Clinical Trial for a novel three-drug combination (known as “Triple Therapy”). Two…